HomeCompareJXFGF vs MRK

JXFGF vs MRK: Dividend Comparison 2026

JXFGF yields 3.45% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.5K in total portfolio value
10 years
JXFGF
JXFGF
● Live price
3.45%
Share price
$0.29
Annual div
$0.01
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$0.35
Full JXFGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — JXFGF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJXFGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JXFGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JXFGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JXFGF
Annual income on $10K today (after 15% tax)
$293.10/yr
After 10yr DRIP, annual income (after tax)
$0.30/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,328.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JXFGF + MRK for your $10,000?

JXFGF: 50%MRK: 50%
100% MRK50/50100% JXFGF
Portfolio after 10yr
$38.5K
Annual income
$4,899.24/yr
Blended yield
12.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JXFGF
No analyst data
Altman Z
1.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JXFGF buys
0
MRK buys
0
No recent congressional trades found for JXFGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJXFGFMRK
Forward yield3.45%2.76%
Annual dividend / share$0.01$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$20.3K$56.8K
Annual income after 10y$0.35$9,798.13
Total dividends collected$348.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JXFGF vs MRK ($10,000, DRIP)

YearJXFGF PortfolioJXFGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,872$172.41$11,206$366.19$334.00MRK
2$11,721$87.60$12,650$502.35$929.00MRK
3$12,586$44.13$14,407$694.19$1.8KMRK
4$13,489$22.14$16,585$967.82$3.1KMRK
5$14,444$11.09$19,342$1,363.89$4.9KMRK
6$15,461$5.55$22,913$1,947.19$7.5KMRK
7$16,546$2.78$27,662$2,823.89$11.1KMRK
8$17,705$1.39$34,159$4,173.35$16.5KMRK
9$18,945$0.69$43,337$6,308.80$24.4KMRK
10$20,272$0.35$56,776$9,798.13$36.5KMRK

JXFGF vs MRK: Complete Analysis 2026

JXFGFStock

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.

Full JXFGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this JXFGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JXFGF vs SCHDJXFGF vs JEPIJXFGF vs OJXFGF vs KOJXFGF vs MAINJXFGF vs JNJJXFGF vs ABBVJXFGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.